VeriSeq PGS
A fully validated next-generation sequencing solution for PGS, providing accurate results in aneuploidy screening and extending future opportunities.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great instrument!
PGT-A diagnostics of trophectoderm cells
It enable high quality results, it is easy to use. People know this manufaturer and its kits well. Reproduction of results depends on sample preparation/handling.
Review Date: 22 Jul 2019 | Illumina
The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of embryos most likely to be euploid. Preimplantation genetic screening (PGS) results generated using VeriSeq PGS are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.
- Industry-leading data quality: More than 90% of the world’s sequencing data is generated by Illumina sequencing by synthesis (SBS) chemistry
- Fast, streamlined workflow: Sample to answer in approximately 12 hours
- High-throughput analysis: Screen up to 24 samples per run
Ultra-Low Input
NGS offers a highly sensitive method for screening embryos, requiring as little as 1 ng of DNA from a SurePlex DNA amplification reaction. DNA can be obtained from a blastomere biopsy, from a day 3 embryo, or from a trophectodermal (TE) biopsy from a blastocyst.
